AiPharma, a global biopharmaceutical company developing innovative antiviral therapies, has completed a rebranding effort in response to company growth and to reflect its expanded business strategy. The company has relaunched under the brand name Cellvera.   This transformation is the result of a redefined strategy that in addition to Cellvera’s exiting flagship, the antiviral portfolio expands its focus on diversified, innovative therapies and other treatment solutions for rare and diff...